Concepedia

Phillip A. Hsieh

PA

Statistics

Publications

9

Citations

446

H-Index

9

Active since

2018

Affiliations

Dana-Farber Cancer Institute(Current)

Kaohsiung Medical University

Kaohsiung Medical University Chung-Ho Memorial Hospital

Tianjin University of Science and Technology

Dana-Farber/Harvard Cancer Center

Phillip A. Hsieh is an author at Dana-Farber Cancer Institute specializing in multiple myeloma therapy, cancer immunotherapy, and multiple myeloma.

Publications per year

2018–2021

9

Publications

9

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma

Liang Lin, Shih‐Feng Cho, Lijie Xing et al. · Leukemia · 2020 · 89 citations · Full text

, , +14

APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications

Yu‐Tzu Tai, Liang Lin, Lijie Xing et al. · Leukemia · 2018 · 86 citations

, , +13

The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models

Shih‐Feng Cho, Liang Lin, Lijie Xing et al. · Blood Advances · 2020 · 71 citations · Full text

, , +17

A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma

Lijie Xing, Liang Lin, Tengteng Yu et al. · Leukemia · 2020 · 62 citations · Full text

, , +17

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Tengteng Yu, Bharat K. R. Chaganty, Liang Lin et al. · Blood Cancer Journal · 2020 · 43 citations · Full text

, , +17

1–5 of 9